According to a new lawsuit filed in Vermont federal court on Monday, Teva Pharmaceuticals acted anticompetitively to “induce health insurers and health plans in the United States to 9 pay billions for its excessively priced multiple sclerosis drug.” The suit was filed by Blue Cross Blue Shield of Vermont and The Vermont Health Plan.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
